Sven Franciscus Anna Van Brandt

USPTO Granted Patents = 38 (Patent Applications = 7)

CIPO Patents = 1

EPO Patents = 15 (Patent Applications = 14)

Average Co-Inventor Count = 6.3

ph-index = 10

Forward Citations = 389(Granted Patents)

Location History:

Turnhoutseweg, BE (2015)
Lier, BE (2015)
Nijlen, BE (2007 - 2017)
Beerse, BE (2013 - 2020)

Company Filing History:

30 out of 2,078

Janssen Pharmaceutica Nv

patents

7 out of 159

Janssen Pharmaceuticals, Inc.

4. 1 out of 832,880

Other

patents

where one patent can have more than one assignee

Years Active: 2007-2020

Loading Chart...

38 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10562897 - Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators (2020-02-18),

2. 10246454 - Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators (2019-04-02),

3. 10106524 - 2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inhibitors of beta-secretase (2018-10-23),

4. 9556161 - Inhibitors of histone deacetylase (2017-01-31),

5. 9150560 - Inhibitors of histone deacetylase (2015-10-06),

6. 9145399 - Substituted bicyclic triazole derivatives as gamma secretase modulators (2015-09-29),

7. 9079886 - Substituted triazole derivatives as gamma secretase modulators (2015-07-14),

8. 8987276 - Substituted triazolyl piperazine and triazolyl piperidine derivatives as gamma secretase modulators (2015-03-24),

9. 8946426 - Substituted bicyclic heterocyclic compounds as gamma secretase modulators (2015-02-03),

10. 8946266 - Substituted triazole and imidazole derivatives as gamma secretase modulators (2015-02-03),

11. 8865720 - Sulfonyl-derivatives as novel inhibitors of histone deacetylase (2014-10-21),

12. 8778919 - Cyclic anilino—pyridinotriazines (2014-07-15),

13. 8772504 - Substituted benzoxazole, benzimidazole, oxazolopyridine and imidazopyridine derivatives as gamma secretase modulators (2014-07-08),

14. 8697717 - Inhibitors of histone deacetylase (2014-04-15),

15. 8557825 - Sulfonyl-derivatives as novel inhibitors of histone deacetylase (2013-10-15),

Title: Sven Franciscus Anna Van Brandt: A Pioneer in Innovation and Patents

Introduction:

Sven Franciscus Anna Van Brandt, hailing from Nijlen, BE, is a visionary inventor whose relentless pursuit of innovation has made him a true trailblazer in the world of patents and inventions. With an impressive portfolio of 38 patents, his remarkable contributions continue to inspire and shape the future of inventors and innovators worldwide.

Latest Patents:

One of his latest patents includes the groundbreaking work on "Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase modulators." This invention introduces novel substituted pyrido-piperazinone derivatives that exhibit promising potential as gamma secretase modulators. The patent encompasses the compounds' preparation processes, pharmaceutical compositions, and their application as medicaments.

Career Highlights:

Van Brandt has made significant strides in his career, with notable affiliations with esteemed companies such as Janssen Pharmaceutica Nv and Janssen Pharmaceuticals, Inc. His innovative prowess and dedication have led to the development of cutting-edge solutions that have the potential to revolutionize the pharmaceutical industry.

Collaborations:

Throughout his career, Van Brandt has collaborated with outstanding professionals in the field, including Kristof Van Emelen and Marc Gustaaf Celine Verdonck. These collaborations have further enriched his work, enabling the realization of groundbreaking inventions that have the power to impact society positively.

Conclusion:

In conclusion, Sven Franciscus Anna Van Brandt's exceptional contributions to the world of patents and inventions underscore his status as a true pioneer in innovation. His dedication, coupled with his inventive spirit, continues to drive progress and inspire future generations of inventors and innovators. Van Brandt's legacy serves as a testament to the transformative power of innovation in shaping a better tomorrow.

This text is generated by artificial intelligence and may not be accurate.